Connection

Andreas Kronbichler to Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Back to Details
This is a "connection" page, showing publications Andreas Kronbichler has written about Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Andreas Kronbichler
Connection Strength
2.008
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  1. ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible? Kidney Int. 2018 12; 94(6):1045-1047.
    View in: PubMed
    Score: 0.585
  2. Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2018 10; 77(10):1440-1447.
    View in: PubMed
    Score: 0.568
  3. Clinical associations with venous thromboembolism in anti-neutrophil cytoplasm antibody-associated vasculitides. Rheumatology (Oxford). 2017 05 01; 56(5):704-708.
    View in: PubMed
    Score: 0.524
  4. COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrol Dial Transplant. 2021 08 27; 36(9):1758-1760.
    View in: PubMed
    Score: 0.177
  5. ANCA associated vasculitis: The journey to complement-targeted therapies. Mol Immunol. 2019 08; 112:394-398.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.